Cargando…

LBSUN292 Learning Lesson From A Case of Fulminant Type 1 Diabetes Mellitus Shortly After Pembrolizumab Treatment

BACKGROUND: Immune checkpoint inhibitors (ICIs) in cancer treatment are considered one of the major breakthroughs in the past decade. Pembrolizumab (PBL) is one of the immune checkpoint inhibitors that targets the programmed cell death protein-1 (PD-1) receptor in order to block its interaction with...

Descripción completa

Detalles Bibliográficos
Autores principales: Phan, Van, Nguyen, Quan, Phan, Vien, Erenler, Feyza, Pittas, Anastassios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629389/
http://dx.doi.org/10.1210/jendso/bvac150.600

Ejemplares similares